Yoshihiko Kitajima

3.3k total citations
85 papers, 2.7k citations indexed

About

Yoshihiko Kitajima is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Yoshihiko Kitajima has authored 85 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 30 papers in Surgery and 29 papers in Cancer Research. Recurrent topics in Yoshihiko Kitajima's work include Cancer, Hypoxia, and Metabolism (22 papers), Gastric Cancer Management and Outcomes (16 papers) and Epigenetics and DNA Methylation (14 papers). Yoshihiko Kitajima is often cited by papers focused on Cancer, Hypoxia, and Metabolism (22 papers), Gastric Cancer Management and Outcomes (16 papers) and Epigenetics and DNA Methylation (14 papers). Yoshihiko Kitajima collaborates with scholars based in Japan, United States and South Korea. Yoshihiko Kitajima's co-authors include Kohji Miyazaki, K. Miyazaki, Takao Ide, Anderson Miyoshi, Hirokazu Noshirο, Wan Jiao, Takao Ohtsuka, Atsushi Miyoshi, Seiji Sato and Kenji Kitahara and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yoshihiko Kitajima

82 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshihiko Kitajima Japan 29 1.6k 956 836 518 413 85 2.7k
Mario Mikula Austria 24 1.8k 1.2× 965 1.0× 633 0.8× 248 0.5× 256 0.6× 53 2.7k
Gregor Krings United States 27 1.2k 0.8× 825 0.9× 813 1.0× 464 0.9× 438 1.1× 62 2.8k
Hiroyuki Hamakawa Japan 32 1.3k 0.8× 1.4k 1.4× 542 0.6× 476 0.9× 439 1.1× 145 3.0k
Koh‐ichi Nakashiro Japan 34 1.7k 1.1× 1.4k 1.5× 802 1.0× 379 0.7× 494 1.2× 127 3.3k
M Imamura Japan 27 1.5k 0.9× 1.2k 1.3× 720 0.9× 831 1.6× 552 1.3× 79 2.9k
Ella Ioffe United States 16 2.3k 1.4× 768 0.8× 643 0.8× 248 0.5× 340 0.8× 24 3.6k
Shiu‐Feng Huang Taiwan 29 1.4k 0.9× 1.2k 1.3× 596 0.7× 327 0.6× 944 2.3× 78 2.9k
Mu-Yan Cai China 33 1.7k 1.1× 735 0.8× 965 1.2× 471 0.9× 473 1.1× 58 2.9k
Hideaki Ijichi Japan 36 2.1k 1.3× 1.9k 2.0× 698 0.8× 733 1.4× 374 0.9× 111 4.0k
Susumu Saigusa Japan 33 1.4k 0.9× 1.5k 1.6× 1.1k 1.3× 601 1.2× 602 1.5× 120 3.2k

Countries citing papers authored by Yoshihiko Kitajima

Since Specialization
Citations

This map shows the geographic impact of Yoshihiko Kitajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshihiko Kitajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshihiko Kitajima more than expected).

Fields of papers citing papers by Yoshihiko Kitajima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshihiko Kitajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshihiko Kitajima. The network helps show where Yoshihiko Kitajima may publish in the future.

Co-authorship network of co-authors of Yoshihiko Kitajima

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshihiko Kitajima. A scholar is included among the top collaborators of Yoshihiko Kitajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshihiko Kitajima. Yoshihiko Kitajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamada, Kohei, Tomokazu Tanaka, Keita Kai, et al.. (2023). Suppression of NASH-Related HCC by Farnesyltransferase Inhibitor through Inhibition of Inflammation and Hypoxia-Inducible Factor-1α Expression. International Journal of Molecular Sciences. 24(14). 11546–11546. 5 indexed citations
2.
Kitajima, Yoshihiko, Hiroshi Kitagawa, Shinichi Aishima, et al.. (2019). Mieap-induced accumulation of lysosomes within mitochondria (MALM) regulates gastric cancer cell invasion under hypoxia by suppressing reactive oxygen species accumulation. Scientific Reports. 9(1). 2822–2822. 12 indexed citations
3.
Kitagawa, Hiroshi, Yoshihiko Kitajima, Keita Kai, et al.. (2019). Predictive value of the ratio of 8‑hydroxydeoxyguanosine levels between cancerous and normal tissues in patients with stage II/III colorectal cancer. Oncology Reports. 41(5). 3041–3050. 11 indexed citations
4.
Baba, Koichi, Yoshihiko Kitajima, S. Miyake, et al.. (2017). Hypoxia-induced ANGPTL4 sustains tumour growth and anoikis resistance through different mechanisms in scirrhous gastric cancer cell lines. Scientific Reports. 7(1). 11127–11127. 52 indexed citations
5.
Kitajima, Yoshihiko, Tomokazu Tanaka, Masao Kaneki, et al.. (2017). Low-dose YC-1 combined with glucose and insulin selectively induces apoptosis in hypoxic gastric carcinoma cells by inhibiting anaerobic glycolysis. Scientific Reports. 7(1). 12653–12653. 22 indexed citations
6.
Miyake, S., Yoshihiko Kitajima, Jun Nakamura, et al.. (2014). Abstract 2096: HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer. Cancer Research. 74(19_Supplement). 2096–2096. 1 indexed citations
7.
Tanaka, Tomokazu, Jun Nakamura, Yoshihiko Kitajima, et al.. (2013). Loss of trefoil factor 1 is regulated by DNA methylation and is an independent predictive factor for poor survival in advanced gastric cancer. International Journal of Oncology. 42(3). 894–902. 21 indexed citations
8.
Hiraki, Masatsugu, Yoshihiko Kitajima, Keita Kai, et al.. (2012). Knockdown of hypoxia-inducible factor-1α accelerates peritoneal dissemination via the upregulation of MMP-1 expression in gastric cancer cell lines. Experimental and Therapeutic Medicine. 4(3). 355–362. 10 indexed citations
9.
Nakamura, Jun, Yoshihiko Kitajima, Keita Kai, et al.. (2011). Expression of Hypoxic Marker CA IX Is Regulated by Site-Specific DNA Methylation and Is Associated with the Histology of Gastric Cancer. American Journal Of Pathology. 178(2). 515–524. 32 indexed citations
10.
Noshirο, Hirokazu, et al.. (2011). Second-line chemotherapy with paclitaxel and doxifluridine after failure of S-1 in elderly patients with unresectable advanced or recurrent gastric cancer. Journal of Cancer Research and Clinical Oncology. 137(10). 1499–1504. 2 indexed citations
11.
Nakafusa, Yuji, Atsushi Miyoshi, Yoshihiko Kitajima, et al.. (2010). Clinical Significance of CEA and CA19-9 in Postoperative Follow-up of Colorectal Cancer. Annals of Surgical Oncology. 17(9). 2349–2356. 68 indexed citations
12.
Aoki, Shigehisa, Yoshihiko Kitajima, Toshiaki Takezawa, et al.. (2010). Epidermal regeneration by keratinocyte-alien mesenchymal cell interactions. Inflammation and Regeneration. 30(5). 428–433. 1 indexed citations
13.
Ohtsuka, Takao, Seiji Sato, Yoshihiko Kitajima, Yuji Nakafusa, & Kohji Miyazaki. (2009). A CASE OF FALSE-POSITIVE FINDING OF TUMOR MARKER AFTER GASTRECTOMY FOR GASTRIC CANCER, WITH CHANGE OF CEA IN PARALLEL WITH GLUCOSE TOLERANCE. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 70(1). 62–65.
14.
Nakamura, Jun, Yoshihiko Kitajima, Keita Kai, et al.. (2009). HIF‐1α is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5‐FU chemotherapy. International Journal of Cancer. 127(5). 1158–1171. 31 indexed citations
16.
Ohtsuka, Takao, Seiji Sato, Yoshihiko Kitajima, et al.. (2007). False-positive Findings for Tumor Markers after Curative Gastrectomy for Gastric Cancer. Digestive Diseases and Sciences. 53(1). 73–79. 10 indexed citations
17.
Ide, Takao, Seiji Sato, Masayuki Tanaka, et al.. (2005). A Resected Case of Advanced Gastric Cancer with Nephrotic Syndrome. The Japanese Journal of Gastroenterological Surgery. 38(5). 490–495. 2 indexed citations
18.
Nakafusa, Yuji, Yoshihiko Kitajima, Seiji Sato, et al.. (2004). Clinical Significance of Direct Invasion to Adjacent Organs in Locally Advanced Colorectal Cancer. The Japanese Journal of Gastroenterological Surgery. 37(9). 1517–1524. 1 indexed citations
19.
Tanaka, Masao, Yoshihiko Kitajima, S Sato, & K. Miyazaki. (2003). Combined evaluation of mucin antigen and E-cadherin expression may help select patients with gastric cancer suitable for minimally invasive therapy. British journal of surgery. 90(1). 95–101. 22 indexed citations
20.
Nakafusa, Yuji, et al.. (2001). Lateral Lymph Node Dissection in Treatment for Advanced Lower Rectal Cancer.. The Japanese Journal of Gastroenterological Surgery. 34(10). 1512–1521. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026